Skip to main content

Advertisement

SpringerLink
Log in

Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To determine the frequency and characteristics of rhegmatogenous retinal detachments (RRDs) that develop after an intravitreal injection of anti-vascular endothelial growth factor (VEGF) agent.

Study design

A retrospective review of the medical charts.

Methods

The charts of patients who received intravitreal injections for age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), or myopic choroidal neovascularization (mCNV) between 2013 and 2020 were reviewed. We included the RRD cases that developed within 90 days of the most recent intravitreal injection. The baseline characteristics and surgical outcomes were analyzed.

Results

A total of 3040 patients received 28,190 intravitreal injections. Seven eyes of 7 cases developed a RRD. There were 6 cases of AMD and one of DME, with an incidence of one in 4027 injections (0.025%). The retinal break was in the superior quadrants in 5 eyes (71%), and in the inferior quadrants in 2 eyes. All eyes had a posterior vitreous detachment. The average number of injections before the development of RRD was 14.1 (range: 2–39). Four eyes were treated by vitrectomy, and 3 by scleral buckling. The primary success rate was 86%, and the final reattachment rate was 100%. The best-corrected visual acuity was 0.41 ± 0.26 logarithm of minimal angle of resolution (logMAR) units before developing the RRD, 0.78 ± 0.78 logMAR units before the surgery for RRD, and 0.45 ± 0.47 logMAR units at the final visit.

Conclusions

The incidence of RRD after an intravitreal injection is very low (0.025%), and it can be reattached with recovery of the visual acuity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol. 2008;246:81–7.

    Article  CAS  Google Scholar 

  2. Day S, Acquah K, Mruthyunjaya P, Grossman DS, Lee PP, Sloan FA. Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. Am J Ophthalmol. 2011;152:266–72.

    Article  CAS  Google Scholar 

  3. Hasler PW, Bloch SB, Villumsen J, Fuchs J, Lund-Andersen H, Larsen M. Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting. Acta Ophthalmol. 2015;93:122–5.

    Article  CAS  Google Scholar 

  4. Baumal CR, Spaide RF, Vajzovic L, Freund KB, Walter SD, John V, et al. Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab. Ophthalmology. 2020;127:1345–59.

    Article  Google Scholar 

  5. Mones J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, et al. Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with Brolucizumab: POST HOC REVIEW of HAWK and HARRIER. Ophthalmology. 2020. https://doi.org/10.1016/j.ophtha.2020.11.011.

    Article  PubMed  Google Scholar 

  6. Meyer CH, Michels S, Rodrigues EB, Hager A, Mennel S, Schmidt JC, et al. Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections. Acta Ophthalmol. 2011;89:70–5.

    Article  CAS  Google Scholar 

  7. Storey PP, Pancholy M, Wibbelsman TD, Obeid A, Su D, Borkar D, et al. Rhegmatogenous retinal detachment after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmology. 2019;126:1424–31.

    Article  Google Scholar 

  8. Mammo DA, Ringeisen AL, Parke DW 3rd. Frequency of rhegmatogenous retinal detachment after intravitreal therapy in neovascular age-related macular degeneration. Ophthalmol Retina. 2020;4(10):973–8.

    Article  Google Scholar 

  9. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13:388–91.

    Article  CAS  Google Scholar 

  10. Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47:1236–40.

    Article  Google Scholar 

  11. Karabag RY, Parlak M, Cetin G, Yaman A, Osman SA. Retinal tears and rhegmatogenous retinal detachment after intravitreal injections: its prevalence and case reports. Digit J Ophthalmol. 2015;21:8–10.

    PubMed  PubMed Central  Google Scholar 

  12. Geck U, Pustolla N, Baraki H, Atili A, Feltgen N, Hoerauf H. Posterior vitreous detachment following intravitreal drug injection. Graefes Arch Clin Exp Ophthalmol. 2013;251:1691–5.

    Article  CAS  Google Scholar 

  13. Kinra V, Singh S, Khanduja S, Nada M. Evaluation of vitreoretinal interface changes in patients receiving intravitreal anti-VEGF therapy. Int Ophthalmol. 2018;38:549–56.

    Article  Google Scholar 

  14. Ryan EH, Joseph DP, Ryan CM, Forbes NJK, Yonekawa Y, Mittra RA, et al. Primary retinal detachment outcomes study: methodology and overall outcomes-primary retinal detachment outcomes study report number 1. Ophthalmol Retina. 2020;4(8):814–22.

    Article  Google Scholar 

  15. Choi YJ, Hyun J, Choi KS, Rhee MR, Lee SJ. Bullous hemorrhagic retinal detachment because of massive subretinal hemorrhage in patients with age-related macular degeneration. Retina. 2013;33:1365–74.

    Article  Google Scholar 

  16. Christoforidis JB, Williams MM, Wang J, Jiang A, Pratt C, Abdel-Rasoul M, et al. Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy. Retina. 2013;33:946–52.

    Article  CAS  Google Scholar 

  17. Shunmugam M, Shah AN, Hysi PG, Williamson TH. The pattern and distribution of retinal breaks in eyes with rhegmatogenous retinal detachment. Am J Ophthalmol. 2014;157(221–6):e1.

    Google Scholar 

  18. Mudvari SS, Ravage ZB, Rezaei KA. Retinal detachment after primary pneumatic retinopexy. Retina. 2009;29:1474–8.

    Article  Google Scholar 

Download references

Acknowledgements

The authors indicate no financial support or financial conflict of interest involved in the design and conduct of the study, the collection of data, management, analysis and interpretation of data, and preparation, review, or approval of the manuscript. The authors thank Professor Emeritus Duco Hamasaki of the Bascom Palmer Eye Institute of the University of Miami for his critical discussion and editing final manuscript.

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-0856, Japan

    Takayuki Baba, Gen Miura, Tomoaki Tatsumi, Madoka Sakurai & Shuichi Yamamoto

Authors
  1. Takayuki Baba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gen Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomoaki Tatsumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Madoka Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuichi Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: TB, GM. Data collection: TB, TT, MS. Analysis and interpretation: TB, SY. Overall responsibility: TB, GM, TT, MS, SY.

Corresponding author

Correspondence to Takayuki Baba.

Ethics declarations

Conflicts of interest

T. Baba, Honorarium for Lecturing (Bayer, Kowa, Santen, Senju, Alcon), Grant, Honorarium for Lecturing (Novartis); G. Miura, None; T. Tatsumi, None; M. Sakurai, None; S. Yamamoto, Grant, Honorarium for Lecturing (HOYA, Senju, Pfizer, Santen, Alcon, Bayer, Kowa), Honorarium for Lecturing (Nikon, Wakamoto, Chuo Sangyo, Sun Contact Lens, Novartis), Consultant fee (Daiichi Sankyo, JAMECS, Findex, Chugai, AbbVie).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Corresponding Author: Takayuki Baba

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baba, T., Miura, G., Tatsumi, T. et al. Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections. Jpn J Ophthalmol 65, 492–496 (2021). https://doi.org/10.1007/s10384-021-00834-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-021-00834-8

Keywords

Search

Navigation